Go Pro
→ Trump's gold order: the announcement they won't put on the front page (From Reagan Gold Group) (Ad)tc pixel Free CAMP Stock Alerts

CAMP4 Therapeutics (CAMP) Competitors

CAMP4 Therapeutics logo
$4.43 +0.09 (+2.07%)
Closing price 07/2/2026 04:00 PM Eastern
Extended Trading
$4.43 0.00 (0.00%)
As of 07/2/2026 07:35 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.
Compare

CAMP vs. NTGR, RBBN, AVNW, KVHI, and CMTL

Should you buy CAMP4 Therapeutics stock or one of its competitors? MarketBeat compares CAMP4 Therapeutics with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with CAMP4 Therapeutics include NETGEAR (NTGR), Ribbon Communications (RBBN), Aviat Networks (AVNW), KVH Industries (KVHI), and Comtech Telecommunications (CMTL). These companies are all part of the "communications equipment" industry.

How does CAMP4 Therapeutics compare to NETGEAR?

NETGEAR (NASDAQ:NTGR) and CAMP4 Therapeutics (NASDAQ:CAMP) are both small-cap communications equipment companies, but which is the better stock? We will contrast the two companies based on the strength of their media sentiment, dividends, earnings, analyst recommendations, profitability, institutional ownership, valuation and risk.

NETGEAR has higher revenue and earnings than CAMP4 Therapeutics. NETGEAR is trading at a lower price-to-earnings ratio than CAMP4 Therapeutics, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
NETGEAR$696.38M0.83-$17.92M-$0.88N/A
CAMP4 Therapeutics$3.93M58.47-$80.40M-$2.36N/A

NETGEAR has a net margin of -3.58% compared to CAMP4 Therapeutics' net margin of -2,193.72%. NETGEAR's return on equity of -2.71% beat CAMP4 Therapeutics' return on equity.

Company Net Margins Return on Equity Return on Assets
NETGEAR-3.58% -2.71% -1.66%
CAMP4 Therapeutics -2,193.72%-194.74%-95.64%

In the previous week, NETGEAR had 2 more articles in the media than CAMP4 Therapeutics. MarketBeat recorded 2 mentions for NETGEAR and 0 mentions for CAMP4 Therapeutics. CAMP4 Therapeutics' average media sentiment score of 1.89 beat NETGEAR's score of 0.86 indicating that CAMP4 Therapeutics is being referred to more favorably in the news media.

Company Overall Sentiment
NETGEAR Positive
CAMP4 Therapeutics Very Positive

NETGEAR presently has a consensus price target of $36.00, suggesting a potential upside of 67.44%. CAMP4 Therapeutics has a consensus price target of $8.36, suggesting a potential upside of 88.65%. Given CAMP4 Therapeutics' stronger consensus rating and higher possible upside, analysts clearly believe CAMP4 Therapeutics is more favorable than NETGEAR.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
NETGEAR
1 Sell rating(s)
1 Hold rating(s)
2 Buy rating(s)
0 Strong Buy rating(s)
2.25
CAMP4 Therapeutics
1 Sell rating(s)
0 Hold rating(s)
7 Buy rating(s)
0 Strong Buy rating(s)
2.75

NETGEAR has a beta of 1.19, meaning that its stock price is 19% more volatile than the broader market. Comparatively, CAMP4 Therapeutics has a beta of 0.1, meaning that its stock price is 90% less volatile than the broader market.

83.0% of NETGEAR shares are held by institutional investors. 3.1% of NETGEAR shares are held by insiders. Comparatively, 21.7% of CAMP4 Therapeutics shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.

Summary

NETGEAR beats CAMP4 Therapeutics on 9 of the 16 factors compared between the two stocks.

How does CAMP4 Therapeutics compare to Ribbon Communications?

Ribbon Communications (NASDAQ:RBBN) and CAMP4 Therapeutics (NASDAQ:CAMP) are both small-cap communications equipment companies, but which is the superior business? We will contrast the two companies based on the strength of their valuation, media sentiment, earnings, profitability, analyst recommendations, risk, institutional ownership and dividends.

Ribbon Communications currently has a consensus target price of $3.58, suggesting a potential upside of 67.29%. CAMP4 Therapeutics has a consensus target price of $8.36, suggesting a potential upside of 88.65%. Given CAMP4 Therapeutics' stronger consensus rating and higher probable upside, analysts clearly believe CAMP4 Therapeutics is more favorable than Ribbon Communications.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Ribbon Communications
1 Sell rating(s)
1 Hold rating(s)
4 Buy rating(s)
0 Strong Buy rating(s)
2.50
CAMP4 Therapeutics
1 Sell rating(s)
0 Hold rating(s)
7 Buy rating(s)
0 Strong Buy rating(s)
2.75

Ribbon Communications has a beta of 1.34, meaning that its stock price is 34% more volatile than the broader market. Comparatively, CAMP4 Therapeutics has a beta of 0.1, meaning that its stock price is 90% less volatile than the broader market.

70.9% of Ribbon Communications shares are owned by institutional investors. 4.0% of Ribbon Communications shares are owned by company insiders. Comparatively, 21.7% of CAMP4 Therapeutics shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.

Ribbon Communications has a net margin of 3.80% compared to CAMP4 Therapeutics' net margin of -2,193.72%. Ribbon Communications' return on equity of 24.14% beat CAMP4 Therapeutics' return on equity.

Company Net Margins Return on Equity Return on Assets
Ribbon Communications3.80% 24.14% 8.35%
CAMP4 Therapeutics -2,193.72%-194.74%-95.64%

In the previous week, Ribbon Communications had 2 more articles in the media than CAMP4 Therapeutics. MarketBeat recorded 2 mentions for Ribbon Communications and 0 mentions for CAMP4 Therapeutics. CAMP4 Therapeutics' average media sentiment score of 1.89 beat Ribbon Communications' score of 0.00 indicating that CAMP4 Therapeutics is being referred to more favorably in the news media.

Company Overall Sentiment
Ribbon Communications Neutral
CAMP4 Therapeutics Very Positive

Ribbon Communications has higher revenue and earnings than CAMP4 Therapeutics. CAMP4 Therapeutics is trading at a lower price-to-earnings ratio than Ribbon Communications, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Ribbon Communications$844.56M0.45$39.64M$0.1712.59
CAMP4 Therapeutics$3.93M58.47-$80.40M-$2.36N/A

Summary

Ribbon Communications beats CAMP4 Therapeutics on 10 of the 16 factors compared between the two stocks.

How does CAMP4 Therapeutics compare to Aviat Networks?

Aviat Networks (NASDAQ:AVNW) and CAMP4 Therapeutics (NASDAQ:CAMP) are both small-cap communications equipment companies, but which is the superior business? We will compare the two businesses based on the strength of their valuation, earnings, risk, analyst recommendations, dividends, media sentiment, institutional ownership and profitability.

Aviat Networks has a beta of 0.7, indicating that its stock price is 30% less volatile than the broader market. Comparatively, CAMP4 Therapeutics has a beta of 0.1, indicating that its stock price is 90% less volatile than the broader market.

78.6% of Aviat Networks shares are held by institutional investors. 5.3% of Aviat Networks shares are held by insiders. Comparatively, 21.7% of CAMP4 Therapeutics shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.

Aviat Networks has a net margin of 2.08% compared to CAMP4 Therapeutics' net margin of -2,193.72%. Aviat Networks' return on equity of 6.89% beat CAMP4 Therapeutics' return on equity.

Company Net Margins Return on Equity Return on Assets
Aviat Networks2.08% 6.89% 2.89%
CAMP4 Therapeutics -2,193.72%-194.74%-95.64%

In the previous week, Aviat Networks had 3 more articles in the media than CAMP4 Therapeutics. MarketBeat recorded 3 mentions for Aviat Networks and 0 mentions for CAMP4 Therapeutics. CAMP4 Therapeutics' average media sentiment score of 1.89 beat Aviat Networks' score of 1.00 indicating that CAMP4 Therapeutics is being referred to more favorably in the news media.

Company Overall Sentiment
Aviat Networks Positive
CAMP4 Therapeutics Very Positive

Aviat Networks presently has a consensus price target of $33.14, suggesting a potential upside of 56.56%. CAMP4 Therapeutics has a consensus price target of $8.36, suggesting a potential upside of 88.65%. Given CAMP4 Therapeutics' stronger consensus rating and higher probable upside, analysts plainly believe CAMP4 Therapeutics is more favorable than Aviat Networks.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Aviat Networks
2 Sell rating(s)
0 Hold rating(s)
8 Buy rating(s)
0 Strong Buy rating(s)
2.60
CAMP4 Therapeutics
1 Sell rating(s)
0 Hold rating(s)
7 Buy rating(s)
0 Strong Buy rating(s)
2.75

Aviat Networks has higher revenue and earnings than CAMP4 Therapeutics. CAMP4 Therapeutics is trading at a lower price-to-earnings ratio than Aviat Networks, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Aviat Networks$434.14M0.63$1.34M$0.6930.68
CAMP4 Therapeutics$3.93M58.47-$80.40M-$2.36N/A

Summary

Aviat Networks beats CAMP4 Therapeutics on 11 of the 16 factors compared between the two stocks.

How does CAMP4 Therapeutics compare to KVH Industries?

CAMP4 Therapeutics (NASDAQ:CAMP) and KVH Industries (NASDAQ:KVHI) are both small-cap communications equipment companies, but which is the superior investment? We will contrast the two companies based on the strength of their earnings, profitability, dividends, institutional ownership, valuation, analyst recommendations, risk and media sentiment.

CAMP4 Therapeutics has a beta of 0.1, suggesting that its share price is 90% less volatile than the broader market. Comparatively, KVH Industries has a beta of 0.43, suggesting that its share price is 57% less volatile than the broader market.

CAMP4 Therapeutics presently has a consensus target price of $8.36, suggesting a potential upside of 88.65%. Given CAMP4 Therapeutics' stronger consensus rating and higher possible upside, research analysts plainly believe CAMP4 Therapeutics is more favorable than KVH Industries.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
CAMP4 Therapeutics
1 Sell rating(s)
0 Hold rating(s)
7 Buy rating(s)
0 Strong Buy rating(s)
2.75
KVH Industries
1 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.00

KVH Industries has a net margin of -4.31% compared to CAMP4 Therapeutics' net margin of -2,193.72%. KVH Industries' return on equity of -0.80% beat CAMP4 Therapeutics' return on equity.

Company Net Margins Return on Equity Return on Assets
CAMP4 Therapeutics-2,193.72% -194.74% -95.64%
KVH Industries -4.31%-0.80%-0.70%

73.7% of KVH Industries shares are owned by institutional investors. 21.7% of CAMP4 Therapeutics shares are owned by insiders. Comparatively, 21.4% of KVH Industries shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth.

In the previous week, CAMP4 Therapeutics' average media sentiment score of 1.89 beat KVH Industries' score of 0.00 indicating that CAMP4 Therapeutics is being referred to more favorably in the media.

Company Overall Sentiment
CAMP4 Therapeutics Very Positive
KVH Industries Neutral

KVH Industries has higher revenue and earnings than CAMP4 Therapeutics. KVH Industries is trading at a lower price-to-earnings ratio than CAMP4 Therapeutics, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
CAMP4 Therapeutics$3.93M58.47-$80.40M-$2.36N/A
KVH Industries$111.01M1.60-$7.38M-$0.26N/A

Summary

KVH Industries beats CAMP4 Therapeutics on 8 of the 15 factors compared between the two stocks.

How does CAMP4 Therapeutics compare to Comtech Telecommunications?

Comtech Telecommunications (NASDAQ:CMTL) and CAMP4 Therapeutics (NASDAQ:CAMP) are both small-cap communications equipment companies, but which is the superior investment? We will compare the two companies based on the strength of their profitability, valuation, analyst recommendations, dividends, media sentiment, institutional ownership, risk and earnings.

Comtech Telecommunications has a beta of 1.51, indicating that its stock price is 51% more volatile than the broader market. Comparatively, CAMP4 Therapeutics has a beta of 0.1, indicating that its stock price is 90% less volatile than the broader market.

In the previous week, CAMP4 Therapeutics' average media sentiment score of 1.89 beat Comtech Telecommunications' score of -0.50 indicating that CAMP4 Therapeutics is being referred to more favorably in the news media.

Company Overall Sentiment
Comtech Telecommunications Negative
CAMP4 Therapeutics Very Positive

Comtech Telecommunications has a net margin of -5.52% compared to CAMP4 Therapeutics' net margin of -2,193.72%. Comtech Telecommunications' return on equity of 9.77% beat CAMP4 Therapeutics' return on equity.

Company Net Margins Return on Equity Return on Assets
Comtech Telecommunications-5.52% 9.77% 1.05%
CAMP4 Therapeutics -2,193.72%-194.74%-95.64%

CAMP4 Therapeutics has lower revenue, but higher earnings than Comtech Telecommunications. CAMP4 Therapeutics is trading at a lower price-to-earnings ratio than Comtech Telecommunications, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Comtech Telecommunications$499.53M0.12-$155.30M-$2.21N/A
CAMP4 Therapeutics$3.93M58.47-$80.40M-$2.36N/A

CAMP4 Therapeutics has a consensus price target of $8.36, suggesting a potential upside of 88.65%. Given CAMP4 Therapeutics' stronger consensus rating and higher probable upside, analysts clearly believe CAMP4 Therapeutics is more favorable than Comtech Telecommunications.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Comtech Telecommunications
1 Sell rating(s)
1 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.50
CAMP4 Therapeutics
1 Sell rating(s)
0 Hold rating(s)
7 Buy rating(s)
0 Strong Buy rating(s)
2.75

Summary

Comtech Telecommunications beats CAMP4 Therapeutics on 7 of the 13 factors compared between the two stocks.

Get CAMP4 Therapeutics News Delivered to You Automatically

Sign up to receive the latest news and ratings for CAMP and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding CAMP and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

CAMP vs. The Competition

Export
MetricCAMP4 TherapeuticsMED IndustryMedical SectorNASDAQ Exchange
Market Cap$230.03M$3.65B$6.82B$12.55B
Dividend YieldN/A2.22%2.68%6.63%
P/E Ratio-1.8821.4327.6824.71
Price / Sales58.47322.60530.0495.30
Price / CashN/A143.2048.5958.15
Price / Book4.348.6611.076.45
Net Income-$80.40M$23.81M$3.57B$336.71M
7 Day Performance5.48%3.47%2.21%1.37%
1 Month Performance6.24%8.53%4.58%1.67%
1 Year Performance208.71%62.64%33.45%24.05%

CAMP4 Therapeutics Competitors List

Export
CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
CAMP
CAMP4 Therapeutics
3.6522 of 5 stars		$4.43
+2.1%		$8.36
+88.6%		+225.7%$230.03M$3.93MN/A644
NTGR
NETGEAR
2.3737 of 5 stars		$23.35
+1.7%		$36.00
+54.2%		-26.1%$616.24M$699.62MN/A690
RBBN
Ribbon Communications
4.1843 of 5 stars		$2.34
+5.4%		$3.58
+53.0%		-48.3%$391.03M$844.56M13.763,080
AVNW
Aviat Networks
4.5201 of 5 stars		$22.20
+7.1%		$32.43
+46.1%		-14.0%$268.23M$434.61M32.17710
KVHI
KVH Industries
0.5207 of 5 stars		$9.91
+3.2%		N/A+68.0%$187.18M$111.01MN/A650

Related Companies and Tools

Related Companies
Top 10 Stock Comparisons

This page (NASDAQ:CAMP) was last updated on 7/3/2026 by MarketBeat.com Staff.
From Our Partners
Trump's gold order: the announcement they won't put on the front page
On August 15, 1971, Nixon interrupted prime-time television and ended the gold standard in 15 minutes - no deb...
Reagan Gold Group | Sponsoredtc pixel
Trump Takes Emergency Action - Plus Elon Musk's New Venture
Elon Musk has quietly launched a new venture - one that has nothing to do with rockets, EVs, or Neuralink. Tru...
Altimetry | Sponsoredtc pixel
Do NOT Buy SpaceX – Do This Instead
SpaceX just went public - and Whitney Tilson, Harvard MBA and 30-year Wall Street veteran, says buying in coul...
Stansberry Research | Sponsoredtc pixel
SPCX Warning - and Worst News for Stocks in 50 Years
Goldman Sachs and Morgan Stanley are now predicting what could be the worst news for the U.S. stock market in ...
TradeSmith | Sponsoredtc pixel
CODE RED: AI Meltdown Imminent?
After correctly predicting the 2008 and 2020 stock market meltdowns, I believe this AI company is about to tri...
Paradigm Press | Sponsoredtc pixel
Trump just signed it
A recent policy development is drawing attention from income-focused investors. According to one analyst, c...
Investors Alley | Sponsoredtc pixel
From the man who predicted 2008 crash…
Porter Stansberry, founder of one of the largest financial research firms in the world, says he's breaking the...
Porter & Company | Sponsoredtc pixel
Your $29.97 book is free today
Why Some Traders Skip Stocks Entirely You don't need a big account to trade options. In fact, options ca...
Profits Run | Sponsoredtc pixel